Nerai Bio
Nerai Bio designs ultra-precise CRISPR enzymes to expand genome-editing targets and enable new therapeutic approaches. The company uses its MORPHEME platform, combining AI-driven design with high-throughput protein engineering and directed evolution to create bespoke genome editors with enhanced specificity. Core technologies include machine learning, CRISPR protein engineering, and large-scale experimental screening. Nerai serves therapeutic and biotech developers working on challenging or rare genetic targets, aiming to enable next-generation gene-editing medicines.
Nerai Bio
Nerai Bio designs ultra-precise CRISPR enzymes to expand genome-editing targets and enable new therapeutic approaches. The company uses its MORPHEME platform, combining AI-driven design with high-throughput protein engineering and directed evolution to create bespoke genome editors with enhanced specificity. Core technologies include machine learning, CRISPR protein engineering, and large-scale experimental screening. Nerai serves therapeutic and biotech developers working on challenging or rare genetic targets, aiming to enable next-generation gene-editing medicines.